Blood

Nature is pleased to acknowledge financial support from Grifols in producing this Outlook. The sponsor retains sole responsibility for the following messages.

For more than 75 years, Grifols has worked to improve the health and well-being of people around the world. Grifols is a global health-care company that produces essential plasma medicines and provides hospitals, pharmacies and health-care professionals with the tools, information and services they need to help them deliver expert medical care.

Grifols’ three divisions — Bioscience, Diagnostic and Hospital — develop, produce and market innovative products and services that are available in more than 100 countries. Headquartered in Barcelona, Spain, Grifols has nearly 15,000 employees in 30 countries.

Grifols’ Bioscience Division is a leading producer of essential plasma medicines for the treatment of rare, chronic and sometimes life-threatening conditions. To help ensure a reliable, consistent source of plasma medicines worldwide, Grifols has an all-inclusive process that begins with plasma collection and continues through fractionation, purification and production at three facilities in Spain and the United States.

Grifols is a leader in transfusion medicine, and its Diagnostic Division advances patient care with diagnostic solutions to improve disease detection and management and simplify laboratory operations. The Hospital Division provides intravenous therapies, clinical nutrition products and hospital pharmacy systems, including automated drug compounding and drug inventory control.

Read the sponsor’s feature.

For more information, please visit www.grifols.com.